Unicycive

Developer of small molecule therapies for the treatment of kidney diseases

placeSan Francisco, California, United States calendar_todayFounded 2016 groups12 employees language unicycive.com

Registered entities

Social engagement

Social engagement: 4.9K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital114%
Private equity343%
Bank & private debt114%
Other / undisclosed229%

Recent activity

4 Jun 2026
Recognition
Coming soon